Price $77.00 |
Market Cap
1.27B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
33.2
|
P/B
2.28
|
P/S
1.53
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
24.6
|
Op. Cash Flow
55.2K
|
FCF
3.2
|
|
Op. Margin
6.60%
|
Net Margin
4.70%
|
ROE
7.20%
|
ROI
5.00%
|
|
ROA
4.50%
|
EPS Growth
21.10%
|
Current Ratio
2.0
|
Debt/Equity
37.40%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Lannett Company, Inc. (LCI) | $2.53 | - | - | 126.8M | Strong Buy |
| Emmaus Life Sciences Inc (EMMA) | $1.62 | - | - | 78.9M | Strong Buy |
| Psychemedics Corp. (PMD) | $8.36 | - | - | 46.6M | Strong Buy |
| Lantheus Holdings Inc (LNTH) | $23.26 | - | - | 1.74B | Strong Buy |
| Recro Pharma Inc (REPH) | $1.85 | - | - | 95.8M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
